NCT00501605View on ClinicalTrials.gov

Phase I Study With AZD2171 in Patients With Advanced Solid Malignant Tumors and Liver Metastases

PHASE1CompletedINTERVENTIONAL
Enrollment

80

Participants

Timeline

Start Date

February 28, 2003

Primary Completion Date

April 30, 2005

Study Completion Date

February 28, 2006

Conditions
Advanced Solid TumorLiver Metastases
Interventions
DRUG

AZD2171

Trial Locations (1)

Unknown

Research Site, Freiburg im Breisgau

Sponsors

Lead Sponsor

AstraZeneca
All Listed Sponsors
lead

AstraZeneca

INDUSTRY